This site is intended for health professionals only

At the heart of general practice since 1960

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Your comments will be sent to our moderator for review.

Report comment to moderator

Required fields.


Using a glitazone second-line in diabetes 'reduces mortality by 30%'


It is a bit of Choose and Book situation : One school is very keen on pioglitazone and considers that it was flawed the way those side effects were reported . The other school is certainly looking at banning glitazones. Between glitazones and gliptins , the former is more potent on HBA1c as the latter only lowers the value by 0.75%.......

Posted date

09 Nov 2012

Posted time